• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Exploration of downstream effector of CTCF using CTCF-mutated uterine endometrial cancer

Research Project

Project/Area Number 21H02793
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Review Section Basic Section 50020:Tumor diagnostics and therapeutics-related
Research InstitutionJapanese Foundation for Cancer Research

Principal Investigator

Mori Seiichi  公益財団法人がん研究会, がんプレシジョン医療研究センター 次世代がん研究シーズ育成プロジェクト, プロジェクトリーダー (10334814)

Co-Investigator(Kenkyū-buntansha) 丸山 玲緒  公益財団法人がん研究会, がん研究所 がんエピゲノムプロジェクト, プロジェクトリーダー (60607985)
杉山 裕子  公益財団法人がん研究会, 有明病院 細胞診断部, 部長 (80322634)
Project Period (FY) 2021-04-01 – 2024-03-31
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥17,420,000 (Direct Cost: ¥13,400,000、Indirect Cost: ¥4,020,000)
Fiscal Year 2023: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2022: ¥5,850,000 (Direct Cost: ¥4,500,000、Indirect Cost: ¥1,350,000)
Fiscal Year 2021: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000)
Keywords子宮体がん / CTCF / エストロゲン / DNAメチル化 / 遺伝子変異 / ドライバー / エストロゲン受容体 / エピゲノム / クロマチン高次構造 / DNAメチローム
Outline of Research at the Start

本研究ではCTCF の変異による子宮体がんのエストロゲン非依存性の獲得ならびにがん化の機序を明らかにする。子宮体がんの既存データを利活用しながら、CTCF 変異型と野生型の腫瘍検体で統計比較を行い、CTCF の下流因子について、特にER 活性制御とDNA メチロームの変化に注目しながら探索する。臨床検体で得られた知見について、CTCF に変異を有する子宮体がんの細胞株やCTCF 野生型の細胞株に変異を導入した細胞株を用いて実験的に実証する。前向きに収集する臨床検体を用いてクロマチン3次元構造解析を行い、DNA メチロームとトランスクリプトームより類推した現象を確認する

Outline of Final Research Achievements

CTCF mutation is commonly found in uterine endometrial cancer and is considered as a driver gene, but the mechanism remains unknown. We investigated changes in DNA methylation and gene expression associated with CTCF mutation using existing omics data and validated them using TCGA data. We confirmed hypermethylation of CTCF binding sites in CTCF-mutated samples in our and TCGA data. CTCF-mutated uterine endometrial cancer had hypermethylation of estrogen receptor binding sites in our data, but not in TCGA data. We confirmed mutations in uterine endometrial cancer driver genes, including CTCF, in CTCF wild-type and mutant endometrioid uterine cancer cell lines, and found no decreased estrogen responsiveness in CTCF-mutated cell lines.

Academic Significance and Societal Importance of the Research Achievements

CTCF のクロマチン構造、遺伝子発現における役割については盛んに研究され多くの知見が得られているが、その変異がどのようにがん化に関わるのか、分子機構はほとんど分かっていない。特に子宮体がんでは大半がCTCF 変異の頻度と位置についての報告に終始し、がん化の機序は全く不明である。本研究により、子宮体がんのエストロゲン非依存性の獲得と腫瘍形成の過程におけるCTCF の役割が明らかになり、さらに新規分子標的治療・ホルモン療法の開発につながるものと期待して本研究を実施した。

Report

(4 results)
  • 2023 Annual Research Report   Final Research Report ( PDF )
  • 2022 Annual Research Report
  • 2021 Annual Research Report
  • Research Products

    (19 results)

All 2024 2023 2022 2021

All Journal Article (14 results) (of which Int'l Joint Research: 8 results,  Peer Reviewed: 14 results,  Open Access: 12 results) Presentation (5 results) (of which Invited: 3 results)

  • [Journal Article] Genetic and epigenetic alterations in precursor lesions of endometrial endometrioid carcinoma2024

    • Author(s)
      Osamu Gotoh, Yuko Sugiyama, Akiko Tonooka, Mayuko Kosugi, Sunao Kitaura, Ryu Minegishi, Masatoshi Sano, Sayuri Amino, Rie Furuya, Norio Tanaka, Tomoko Kaneyasu, Kohei Kumegawa, Akiko Abe, Hidetaka Nomura, Yutaka Takazawa, Hiroyuki Kanao, Reo Maruyama, Tetsuo Noda, Seiichi Mori.
    • Journal Title

      Journal of Pathology

      Volume: -

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Clinical landscape of TP73 structural variants in ATL patients2023

    • Author(s)
      Hiramatsu Hiroaki、Yokomori Rui、Shengyi Liu、Tanaka Norio、Mori Seiichi、Kiyotani Kazuma、...., Imaizumi Yoshitaka、Iida Shinsuke、Utsunomiya Atae、Noda Tetsuo、Nishikawa Hiroyoshi、Ueda Ryuzo、Sanda Takaomi、Ishida Takashi
    • Journal Title

      Leukemia

      Volume: 37 Issue: 12 Pages: 2502-2506

    • DOI

      10.1038/s41375-023-02059-9

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice2023

    • Author(s)
      Fukada Ippei、Mori Seiichi、Hayashi Naomi、Hosonaga Mari、Xiaofei Wang、Yamazaki Masumi、Ueki Arisa、Kiyotani Kazuma、Tonooka Akiko、Takeuchi Kengo、Ueno Takayuki、Takahashi Shunji
    • Journal Title

      Cancer Science

      Volume: 114 Issue: 12 Pages: 4632-4642

    • DOI

      10.1111/cas.15993

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility2023

    • Author(s)
      Kumegawa Kohei、Saeki Sumito、Takahashi Yoko、Yang Liying、Osako Tomo、Nakadai Tomoyoshi、Amino Sayuri、Maeda Tetsuyo、Takahata Chikako、Mori Seiichi、Noda Tetsuo、Ohno Shinji、Ueno Takayuki、Maruyama Reo
    • Journal Title

      British Journal of Cancer

      Volume: 128 Issue: 7 Pages: 1208-1222

    • DOI

      10.1038/s41416-023-02178-1

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Transcriptomic Analyses of Pretreatment Tumor Biopsy Samples, Response to Neoadjuvant Chemoradiotherapy, and Survival in Patients With Advanced Rectal Cancer2023

    • Author(s)
      Akiyoshi Takashi、Wang Zhe、Kaneyasu Tomoko、Gotoh Osamu、Tanaka Norio、Amino Sayuri、Yamamoto Noriko、Kawachi Hiroshi、Mukai Toshiki、Hiyoshi Yukiharu、Nagasaki Toshiya、Yamaguchi Tomohiro、Konishi Tsuyoshi、Fukunaga Yosuke、Noda Tetsuo、Mori Seiichi
    • Journal Title

      JAMA Network Open

      Volume: 6 Issue: 1 Pages: e2252140-e2252140

    • DOI

      10.1001/jamanetworkopen.2022.52140

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Druggable gene alterations in Japanese patients with rare malignancy2022

    • Author(s)
      Ohmoto Akihiro、Hayashi Naomi、Fukada Ippei、Yamazaki Masumi、Yunokawa Mayu、Kasuga Akiyoshi、Shinozaki Eiji、Ueki Arisa、Tonooka Akiko、Takeuchi Kengo、Mori Seiichi、Kiyotani Kazuma、Takahashi Shunji
    • Journal Title

      Neoplasia

      Volume: 33 Pages: 100834-100834

    • DOI

      10.1016/j.neo.2022.100834

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Genomic features of <i>Helicobacter pylori</i> ‐na?ve diffuse‐type gastric cancer2022

    • Author(s)
      Namikawa Ken、Tanaka Norio、Ota Yuki、Takamatsu Manabu、Kosugi Mayuko、Tokai Yoshitaka、Yoshimizu Shoichi、Horiuchi Yusuke、Ishiyama Akiyoshi、Yoshio Toshiyuki、Hirasawa Toshiaki、Amino Sayuri、Furuya Rie、Gotoh Osamu、Kaneyasu Tomoko、Nakayama Izuma、Imamura Yu、Noda Tetsuo、Fujisaki Junko、Mori Seiichi
    • Journal Title

      The Journal of Pathology

      Volume: 258 Issue: 3 Pages: 300-311

    • DOI

      10.1002/path.6000

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma.2022

    • Author(s)
      Tanaka N, Mori S, Kiyotani K, ・・・(他15名)・・・ Nishikawa H, Ueda R, Ishida T
    • Journal Title

      Haematologica. 107

      Volume: 107 Issue: 10 Pages: 2418-2431

    • DOI

      10.3324/haematol.2021.280352

    • Related Report
      2022 Annual Research Report 2021 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer2022

    • Author(s)
      Kumegawa Kohei、Takahashi Yoko、Saeki Sumito、Yang Liying、Nakadai Tomoyoshi、Osako Tomo、Mori Seiichi、Noda Tetsuo、Ohno Shinji、Ueno Takayuki、Maruyama Reo
    • Journal Title

      npj Breast Cancer

      Volume: 8 Issue: 1 Pages: 70-70

    • DOI

      10.1038/s41523-022-00438-6

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types2022

    • Author(s)
      Takamatsu Shiro、Brown J.B.、Yamaguchi Ken、Hamanishi Junzo、Yamanoi Koji、Takaya Hisamitsu、Kaneyasu Tomoko、Mori Seiichi、Mandai Masaki、Matsumura Noriomi
    • Journal Title

      JCO Precision Oncology

      Volume: - Issue: 6

    • DOI

      10.1200/po.22.00085

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] A method of sample-wise region-set enrichment analysis for DNA methylomics2021

    • Author(s)
      Minegishi Ryu、Gotoh Osamu、Tanaka Norio、Maruyama Reo、Chang Jeffrey T、Mori Seiichi
    • Journal Title

      Epigenomics

      Volume: 13 Issue: 14 Pages: 1081-1093

    • DOI

      10.2217/epi-2021-0065

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms2021

    • Author(s)
      Mori S, Gotoh O, Kiyotani K, Low SK
    • Journal Title

      Journal of Human Genetics

      Volume: 66 Issue: 9 Pages: 853-868

    • DOI

      10.1038/s10038-021-00940-y

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Pathogenicity assessment of variants for breast cancer susceptibility genes based on BRCAness of tumor sample2021

    • Author(s)
      Yoshida R, Hagio T, Kaneyasu T, Gotoh O, Osako T, Tanaka N, Amino S, Yaguchi N, Nakashima E, Kitagawa D, Ueno T, Ohno S, Nakajima T, Nakamura S, Miki Y, Hirota T, Takahashi S, Matsuura M, Noda T, Mori S.
    • Journal Title

      Cancer Sci.

      Volume: 112(3) Issue: 3 Pages: 1310-1319

    • DOI

      10.1111/cas.14803

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Immunogenomic landscape of gynecologic carcinosarcoma2021

    • Author(s)
      Gotoh Osamu、Kiyotani Kazuma、Chiba Tomohiro、Sugiyama Yuko、Takazawa Yutaka、Nemoto Kensaku、Kato Kazuyoshi、Tanaka Norio、Nomura Hidetaka、Hasegawa Kosei、Fujiwara Keiichi、Takamatsu Shiro、Matsumura Noriomi、Noda Tetsuo、Mori Seiichi
    • Journal Title

      Gynecologic Oncology

      Volume: 160 Issue: 2 Pages: 547-556

    • DOI

      10.1016/j.ygyno.2020.11.030

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Presentation] 子宮体癌の前駆病変である内膜増殖症におけるゲノム・エピゲノム異常2023

    • Author(s)
      後藤理, 杉山裕子, 外岡暁子, 千葉知宏, 野田哲生, 森誠一
    • Organizer
      第82回日本癌学会学術総会
    • Related Report
      2023 Annual Research Report
  • [Presentation] 遺伝性乳がん卵巣がん症候群の家系員における高リスク病原性遺伝子の予期せぬ検出2023

    • Author(s)
      吉田玲子, 野田哲生, 中村清吾, 森誠一
    • Organizer
      第82回日本癌学会学術総会
    • Related Report
      2023 Annual Research Report
    • Invited
  • [Presentation] 子宮内膜増殖性病変に対する妊孕性温存黄体ホルモン療法の治療効果予測に関する研究2023

    • Author(s)
      杉山裕子, 後藤理, 外岡暁子, 野田哲生, 森誠一
    • Organizer
      第82回日本癌学会学術総会
    • Related Report
      2023 Annual Research Report
  • [Presentation] 全ゲノム解析等実行計画における患者還元2023

    • Author(s)
      上野貴之, 深田一平, 森誠一
    • Organizer
      第82回日本癌学会学術総会
    • Related Report
      2023 Annual Research Report
    • Invited
  • [Presentation] プレシジョン医療の現況:オーバービューと我々の知見2023

    • Author(s)
      森誠一
    • Organizer
      第61回日本癌治療学会学術集会
    • Related Report
      2023 Annual Research Report
    • Invited

URL: 

Published: 2021-04-28   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi